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Abstract 
Background: Diabetic neuropathy in visceral organs such as the gastrointestinal (GI) tract is still poorly understood, 
despite that GI symptoms are among the most common diabetic complications. The present study was designed to 
explore the changes in visceral sensitivity and the underlying functional and morphological deficits of the sensory 
nerves in short-term diabetic rats. Here, we compared the colorectal distension (CRD)-induced visceromotor response 
(VMR, an index of visceral pain) in vivo, the mechanosensitivity of colonic afferents ex vivo as well as the expression 
of protein gene product (PGP) 9.5 and calcitonin gene-related peptide (CGRP) in colon between diabetic (3–6 weeks 
after streptozotocin injection) and control (age-matched vehicle injection) rats.
Results: VMR was markedly decreased in the diabetic compared to the control rats. There was a significant decrease 
in multiunit pelvic afferent nerve responses to ramp distension of the ex vivo colon and single unit analysis indicated 
that an impaired mechanosensitivity of low-threshold and wide dynamic range fibers may underlie the afferent 
hyposensitivity in the diabetic colon. Fewer PGP 9.5- or CGRP-immunoreactive fibers and lower protein level of PGP 
9.5 were found in the colon of diabetic rats.
Conclusions: These observations revealed the distinctive feature of colonic neuropathy in short-term diabetic rats 
that is characterized by a diminished sensory innervation and a blunted mechanosensitivity of the remnant sensory 
nerves.
Keywords: Diabetes, Visceral hyposensitivity, Primary afferents, Calcitonin gene-related peptide (CGRP), Protein gene 
product 9.5 (PGP 9.5)
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Background
Diabetic neuropathies are heterogeneous, affecting dif-
ferent parts of the peripheral nervous system and result-
ing in diverse symptoms. Most common among the 
neuropathies are chronic sensorimotor distal symmetric 
polyneuropathy and autonomic neuropathies. Somatic 
sensory neuropathy is known to result in neuropathic 
pain, loss of sensation and contribute to the development 
of diabetic foot ulceration. The manifestations of visceral 
neuropathy are often more unpredictable, but gastro-
intestinal (GI) symptoms such as gastroparesis, post-
prandial fullness, nausea, vomiting, bloating, diarrhea 
and constipation are amongst the most common clinical 
presentations of diabetes. The symptoms are often severe 
and substantially decrease the quality of life [1].
The mechanisms underlying the pathogenesis of the 
GI symptoms in the course of diabetes are undoubtedly 
multifactorial, including motor dysfunction, altered vis-
ceral sensitivity, altered gut hormone secretion, central 
neuroplastic changes as well as psychological and genetic 
factors (see references in [2]). As clinical management of 
these patients is often challenging, a better understand-
ing of GI sensory processing in the diabetic condition is 
needed.
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Alterations in upper GI sensation in diabetic patients 
have been studied vigorously. An increased sensory 
response to gastric distension was observed in dia-
betic patients [3, 4]. In contrast, hyposensitivity in the 
oesophagus and duodenum to various stimuli includ-
ing mechanical, thermal and electrical stimulations was 
observed in diabetic patients with evident DAN and GI 
symptoms [5]. More recently, functional brain imaging 
studies have provided evidence that the CNS processing 
of visceral sensation is altered in diabetic patients with 
upper GI symptoms [6, 7].
Sensory deficits in the lower GI tract have also long 
been recognized and are suspected to be associated with 
symptoms such as diarrhea and constipation in dia-
betic patients [8–10]. However, few studies have directly 
assessed the morphological and functional changes in the 
primary afferent nerves innervating the lower GI tract 
and there is a lack of mechanistic understanding of the 
sensory deficits of the lower GI in diabetic conditions. 
Previously, Beyak and colleagues recorded the mecha-
nosensitive response of rectal afferents in a flat-sheet rat 
rectum preparation and found that streptozotocin (STZ)-
induced experimental diabetes selectively impaired the 
detection of low threshold ‘physiological’ rectal distention, 
such as that which might occur during rectal filling [11]. 
In contrast, Grabauskas et al. reported that a diminished 
KV4.2 current in DRG neurons might underlie colorectal 
hypersensitivity in STZ-induced diabetic rats [12]. In the 
present study we aim to explore visceral sensitivity and 
the underlying morphological and funtional alterations in 
the afferent innervation of the colorectum in the diabetic 
condition. To this end, we compared colorectal distension 
(CRD)-induced visceromotor response (VMR) in  vivo, 
the mechanosensitivity of the colonic afferent nerves in 
the ex vivo colon preparations as well as the expression of 
protein gene product 9.5 (PGP 9.5) and calcitonin gene-
related peptide (CGRP) in the colon of STZ-induced 
short-term diabetic and age-matched vehicle-treated rats.
Results
About sixty-seven percent of rats (27/40) treated with 
STZ displayed sustained hyperglycemia (>15  mmol/L) 
since day 3, whereas the blood glucose level of the con-
trol rats remained unaltered (Fig. 1a). Concomitantly, the 
mean paw withdrawal threshold of the diabetic group 
was significantly lower than that of the control group 
(Fig.  1b). These data are indicative of the development 
of somatic mechanical hypersensitivity in STZ-induced 
short-term diabetic rats.
Decreased VMR to CRD in diabetic rats
Visceromotor responses to colorectal distension were 
examined in control and diabetic (3–6  weeks after 
injection of STZ) rats. As shown in Fig.  2a, the VMRs 
had a threshold of approximately 30.7  ±  3.6  mmHg 
and the amplitude increased linearly with the disten-
sion pressure in non-diabetic rats, while VMRs had an 
threshold of 50.4  ±  3.8  mmHg in diabetic rats which 
was significantly higher than that in the non-diabetic 
rats (P < 0.001, unpaired t test). Furthermore, the aver-
aged pressure-response curve of VMRs was shifted 
downward in diabetic rats compared with the non-dia-
betic rats. Unpaired t-test of the area under the curves 
(AUC) indicated that the amplitude of VMR was signifi-
cantly lower in diabetic than in control rats (P < 0.001, 
Fig.  2b). These results showed that the pseudoaffective 
responses to colorectal distension were diminished in 
early diabetes.
Fig. 1 Effects of single STZ injection (50 mg/kg, i.p.) on rat blood 
glucose level and paw withdrawal threshold. a Blood glucose level 
was significantly increased since day 3 after STZ injection. b Paw with-
drawal threshold was significantly decreased since the second week 
after STZ injection. ***P < 0.001, two-way ANOVA with Bonferroni’s 
posttest
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Decreased mechanosensitivity of pelvic afferents 
innervating colon in diabetic rats
To test the possibility that impaired afferent innervation 
of the colorectum may underlie the diminished VMRs 
in diabetic rats, we compared the mechanosensitivity of 
pelvic afferents in the ex  vivo colon preparations from 
diabetic and control rats. As shown in Fig. 3a, b, which 
are examples of multiunit activity in control and dia-
betic preparations, the colonic afferent nerves had a low 
level of irregular spontaneous activity (Control: 17 ± 8.9 
imp/s, Diabetic: 23 ± 7.9 imp/s; P > 0.05, unpaired t test) 
and ramp distension of the colon induced an increase in 
the firing rate. The averaged pressure-response curve of 
the multiunit activity was shifted downward in the dia-
betic preparations compared to the control preparations. 
Unpaired t-test of AUC indicated that distension-induced 
multiunit activity was significantly lower in diabetic than 
in control preparations (P < 0.01, Fig. 3c).
Through the principal component analysis, two to four 
mechanosensitive units were identified in each multiunit 
recording. Colonic afferent fibers consist of three distinct 
populations according to the profiles of the responses 
to distension, namely low threshold (LT) fibers, wide 
dynamic range (WDR) fibers and high threshold (HT) 
fibers (Fig.  3a, b). Low threshold (LT) units were char-
acterized by a very LT to distention, reaching a maxi-
mal firing rate at about 20 mmHg. There was no further 
increase in discharge in these afferents with further 
increases in pressure up to 60  mmHg. High threshold 
(HT) units had thresholds >20 mmHg, but the responses 
to encoded stimulus intensities were relative low. Wide 
dynamic range (WDR) units had a low threshold, how-
ever, continued to encode stimulus intensities across the 
range, and their pressure–response relationship mimics 
that of the whole-nerve activity.
Among the 31 single fibers in control rats, 6 (19.3  %) 
LT units, 22 (71.0 %) WDR units and 3 (9.7 %) HT units 
were identified. Similar proportions of LT (9/37, 24.3 %), 
WDR (22/37, 59.5  %) and HT (6/37, 16.2  %) units were 
identified in diabetic rats. There was no significant dif-
ference in the distribution of three types of response 
profile in diabetic and control rats (p  =  0.629, Fisher’s 
exact test). However, the pressure-response curves of LT 
and WDR units of diabetic rats were shifted downward 
(Fig. 3c) and the corresponding AUC values were signifi-
cantly smaller as compared to those of the control rats 
(P < 0.05 and P < 0.01 for LT and WDR units, diabetic vs 
control, unpaired t test, Fig.  3c). The pressure-response 
curves of the HT units of diabetic and non-diabetic rats 
were not significantly different. These results suggest that 
the mechanosensitivities of the LT and the WDR afferent 
fibers of the colon were blunted in the diabetic condition.
Decreased PGP 9.5 and CGRP expression in the colon 
of diabetic rats
To investigate the possibility that the density of afferent 
innervation of the colon might be altered in the diabetic 
condition, we performed immunofluorescent stain-
ing for PGP 9.5 (a general neuronal marker) and CGRP 
(a C- and Aδ sensory fiber marker) to visualize affer-
ent neurites within the colon tissue. Neurites immuno-
reactive for PGP 9.5 or CGRP could be detected in the 
mucosa, the submucosa and the muscle layer of the colon 
and appeared to be more sparse in the diabetic than in 
the control rat colon tissue (Fig.  4 top). Neurite count-
ing showed a significant reduction of neurite density in 
the diabetic (116.5  ±  9.9 PGP 9.5+-neurites/mm2 and 
49.7  ±  10.9 CGRP+-neurites/mm2) as compared to the 
control colon tissue (336.8  ±  20.9 PGP 9.5+-neurites/
mm2 and 182.0 ±  5.6 CGRP+-neurites/mm2, P  <  0.001, 
unpaired t test, Fig.  4 bottom). In addition, western 
blot analysis revealed a significant reduction in PGP 9.5 
expression in the diabetic rat colon (Fig. 5).
Discussion
Somatic neuropathy induced by diabetes has been stud-
ied extensively in recent years [13–18]. In contrast, 
Fig. 2 The visceromotor responses (VMR) to colorectal distension in 
diabetic and control rats. a Representative recordings of CRD-induced 
VMRs in control and diabetic rats. b The relationship between the 
VMR rate and the distention pressure in age-matched control (n = 7) 
and diabetic (n = 9) rats. A significant decrease in VMR occurred in 
diabetic rats compared with control rats. ***P < 0.001, un-paired t test 
of the area under curves (AUC)
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diabetic neuropathy in visceral organs such as the gastro-
intestinal (GI) tract is still poorly understood. In the pre-
sent study, we found that in the early stage (3–6 weeks) 
of STZ-induced diabetes, rats developed colorectal hypo-
sensitivity with concomitant decreases of the mecha-
nosensitivity and the density of primary afferent fibers 
innervating the colorectum.
In rodents, the most common experimental model of 
short-term insulin-deficient diabetes is the elimination 
of pancreatic β islet cells by administration of STZ [19]. 
In the present study, rats treated with STZ (50  mg/Kg, 
i.p.) developed sustained hyperglycemia since day 3 and 
in keeping with previous reports they developed somatic 
mechanical hypersensitivity [20].
We assessed the sensitivity of the lower GI tract in the 
diabetic rats by recording the viscero-motor responses 
(VMR, i.e., abdominal EMG) during gradual colorectal 
distension. CRD-induced VMR, akin to the paw with-
drawal reflex upon noxious pinch, is a nocifensive reflex 
elicited by nociceptive signals originating from the colo-
rectum. We found that compared to the non-diabetic 
rats, diabetic rats showed a relative insensitivity to CRD, 
as manifested by a higher distension pressure required to 
evoke VMR (higher threshold) and a lower VMR magni-
tude. Notably, such colorectal hyposensitivity occurred at 
3–6  weeks following STZ treatment, which was consid-
ered as the early stage of STZ-induced diabetes [11, 16]. 
In contrast, Grabauskas et al. [12] and Romanovsky et al. 
[21] reported colorectal hypersensitivity in rats 8 and 
2 weeks after STZ injection, respectively. The reasons for 
these discrepancies remains to determined, however, it 
might be due to the different pattern of stimulation (i.e., 
continuously gradual distention of colon in current study 
vs. intermittently graded distention of colon in other 
studies). Another possibility is that colorectal sensitiv-
ity may alter dynamically as diabetes progresses because 
the experiments tested at different time points after STZ 
injection were seen in these studies. In this regard, it is 
interesting to note that in previous reports somatic ther-
mal hyperalgesia [13, 18] and hypoalgesia [13, 22] were 
described in short-term (2–8  weeks) and longer-term 
(≥12 weeks) STZ-induced diabetic rats, respectively.
Fig. 3 The mechanosensitivity of the pelvic afferent nerves in the ex vivo rat colorectum preparations. a and b show representative recording of 
multiunit afferent activity during ramp distension of the colorectum. From top to bottom are traces of the pressure, raw (multiunit) neurogram, the 
multiunit discharge frequency and the discharge rate of low threshold (LT), wide dynamic range(WDR) and high threshold(HT) units discriminated 
through principal component analysis. c shows the averaged pressure-response curves of multiunits (n = 17 and 23), LT (n = 6 and 9), WDR (n = 22 
and 22) and HT units (n = 3 and 6) of the control and diabetic groups.*P < 0.05; **P < 0.01, un-paired t test of AUC
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VMR is a nocifensive reflex that involves both periph-
eral and central neuronal pathways. To address the 
contribution of the peripheral nerves in the colorectal 
hyposensitivity in short-term diabetes, we examined the 
distension-induced pelvic nerve discharge in the ex vivo 
colorectum preparation taken from control and diabetic 
rats. Multiunit recording demonstrated a significantly 
diminished afferent nerve response to ramp distension 
of the colorectum. Single-unit analysis revealed a lower 
mechaosensitivity of the low threshold (LT) and the wide 
dynamic range (WDR) fibers in diabetic rats than in non-
diabetic rats. These results are consistent with a recent 
study by Beyak et al., who studied the stretch responses 
of pelvic afferents in a flat-sheet rat rectum preparation 
and found that the LT and the WDR fibers of diabetic 
rats (4–8 weeks after STZ injection) were less sensitive to 
stretch than those of non-diabetic rats [11]. These find-
ings indicate that functional deficits of the primary affer-
ents contribute to the colorectal hyposensitivity seen in 
the short-term diabetic condition.
Previous studies showed that loss of intraepidermal 
afferent fibers led to somatic mechanical hypoalgesia in 
STZ-induced diabetic rats (12  weeks after STZ injec-
tion) and mice (4–8 weeks after STZ injection) [22, 23]. 
To explore the possibility that loss of afferent fibers may 
also underlie the colorectal hyposensitivity in the early 
diabetic rats, we conducted immunofluorescent staining 
of nerve fibers within the colorectum using PGP 9.5 as 
a pan-neuronal marker and CGRP as a selective marker 
for Aδ- and C-fibers [24]. We found that the density 
of CGRP-immunoreactive neurites in the colon tissue 
was significantly decreased in the diabetic than in the 
non-diabetic rats, as was the density of PGP 9.5-immu-
noreactive neurites. In addition, western blot analysis 
showed that the protein level of PGP 9.5 was decreased 
in the colon from diabetic rats. These findings confirm 
a loss of peripheral nerve fibers, especially the nocicep-
tive sensory fibers of the colorectum in early diabetic 
rats.
Intriguingly, we found that the rats early in the course 
of diabetes showed somatic mechanical hypersensitiv-
ity but visceral mechanical hyposensitivity. This indi-
cates that the different responses of nervous systems 
to hyperglycemia do occur between somata and vis-
cera. One possibility is the different characteristics 
of primary afferent nerves between somata and vis-
cera. Most of the sensory nerves innervated to viscera 
are c-(unmyelinated) and Aδ (thin myelinated) fib-
ers, while the sensory nerves innervated to somata are 
thick myelinated Aβ fibers that usually contribute to the 
somatic inflammatory and neuropathic pain except for 
the c- and Aδ fibers. Another possibility is the different 
changes in microenvironments surround the afferents 
Fig. 4 The PGP 9.5- or CGRP- immunoreactive neurites in the colon 
from control and diabetic rats. Top Representative microphotographs 
of PGP 9.5- or CGRP-immunoreactive neurites in the colon from con-
trol and diabetic rats. Bottom The bar graph showing the number of 
neurites expressed PGP 9.5 or CGRP in control and diabetic rats. Both 
PGP 9.5- and CGRP-immunoreactive neurites were much more less in 
all layers of the colon in diabetic rats (n = 7) than those in control rats 
(n = 5). ***p < 0.001 vs. control, unpaired t test
Fig. 5 The protein levels of PGP 9.5 in the colon from control and 
diabetic rats. Top Representative bands of PGP 9.5 (MW: 27 kDa) and 
β-actin (MW: 42 kDa) in the colon from control and diabetic rats. 
Bottom Bar graph showed the relative density of PGP 9.5 in the colon 
from control and diabetic rats. Protein level of PGP 9.5 was decreased 
in the colon from diabetic rats (n = 6) compared to control rats 
(n = 4). *P < 0.05 vs. control, unpaired t test. C control, D diabetic
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between samata and viscera after diabetes. The mecha-
nisms underlying the different responses will be further 
explored in the future studies.
Painful or painless peripheral neuropathy is a frequent 
and severe complication of diabetes. Although chronic 
hyperglycemia play an important role in the pathogenesis 
of diabetic neuropathy, other factors, such as insulinope-
nia, dyslipidemia, insulin resistance, oxidative stress and 
abnormalities in insulin-like growth factors production, 
are likely to play a precipitating role. The mechanisms 
underlying visceral diabetic neuropathy requires large 
longitudinal studies to be explored.
Conclusion
The present study provides data that shows diminished 
visceromotor responses to colorectal distension in dia-
betic rats 3–6 weeks after STZ injection. Concomitantly, 
the mechanosensitive responses of the low threshold and 
the wide dynamic range afferent fibers of the colorectum 
were significantly decreased, and the density of PGP 9.5- 
or CGRP-immunoreactive fibers was diminished in the 
diabetic rats. These findings suggest that visceral hypo-
sensitivity may develop early in the course of diabetes 
due to both functional and structural deficits of the pri-
mary afferent nerves.
Methods
Male Sprague–Dawley rats (190–210  g) were housed 
(three animals per cage) in a temperature controlled 
room (22–25 °C) illuminated from 07:00 to 19:00 h. Food 
and water were available ad libitum. All animal care and 
experimental protocols complied with the Guiding Prin-
ciples in the Care and Use of Animals and the Animal 
Management Rule of the Ministry of Public Health, Peo-
ple’s Republic of China (documentation 545, 2001).
Induction of diabetes
The most commonly used experimental model of dia-
betes in rodents is the elimination of pancreatic β islet 
cells by administration of STZ. STZ-induced diabetes 
produces early functional and biochemical abnormali-
ties within peripheral nerves of rats and mice similar to 
those observed in human diabetic neuropathy [19]. Dia-
betes was induced in male Sprague–Dawley rats by an 
intraperitoneal (i.p.) injection of STZ (50 mg/kg, n = 40) 
dissolved in 0.01 M cold citrate buffer (pH 4.0). Control 
rats (n = 20) were injected with the same volume of vehi-
cle (0.01  mol/L citrated buffer). From day 3 after injec-
tion, blood glucose level was checked weekly using the 
glucose-oxidase test strip and a reflectance meter (Roche 
Diagnostics GmbH, Ireland) on blood samples obtained 
from a tail prick. The animals showing a sustained hyper-
glycemia (27/40, 67.5 %) were used for comparison of the 
visceral sensitivity and the expression of neuronal mark-
ers 3–6 weeks after injection of STZ or vehicle.
Colorectal distention (CRD)‑induced visceromotor 
responses (VMR)
CRD-induced VMR is a pseudoaffective response 
induced by noxious stimulation of the viscera and has 
been used extensively to evaluate visceral sensitivity in 
experimental animals [25]. To assess the changes in colo-
rectal sensitivity in early diabetes, STZ-treated rats with 
sustained hyperglycemia (n  =  9) were anesthetized by 
i.p. injection of pentobarbital sodium (60 mg/kg) and the 
rats’ body temperature were kept around 37.5  °C using 
a thermostatic blanket. A lubricated polyethylene bal-
loon (3 cm long, 1.5 cm max diameter) was inserted into 
the colorectum (the distal end of the balloon was about 
2 cm proximal to the anus) for gradual CRD. The balloon 
was connected to a pressure control device and a pres-
sure sensor. Two silver wire electrodes were implanted 
into the musculus obliques externus abdominis and rec-
tus abdominis and a reference electrode was inserted 
subcutaneously to record the eletromyogram (EMG) 
induced by CRD. The balloon pressure and EMG signals 
were fed via the Powerlab interface into a computer and 
analyzed by Chart software (Powerlab; AD Instrument, 
Bella Vista, Australia). Following the surgical prepara-
tion which is usually lasted about 1  h, the rat was kept 
under light anesthesia via inhalation of 1 % isoflurane and 
was allowed at least 30 min to acclimatize before the test 
began. CRD was performed via gradually inflating the 
balloon up to a pressure of 80 mmHg within 2 min and 
this was repeated at 10 min intervals. Generally, 6 trials 
were run to achieve a stable response (less than 20 % vari-
ability between the last two trials). The same experimen-
tal paradigm was completed with age-matched control 
rats (n = 7).
The ex vivo colon preparation and pelvic afferent nerve 
recording
At 4–5  weeks after induction of diabetes mellitus, rats 
(n  =  5) were deeply anaesthetized with pentobarbi-
tal (80  mg/kg, i.p.). The abdominal cavity was exposed 
by a midline incision on the abdominal wall. The colon 
3  cm proximal to the anal sphincter with the attached 
pelvic ganglia and pelvic nerves was removed and was 
placed into a recording chamber (20  mL), where it was 
superfused continuously at a rate of 15  mL/min with 
oxygenated Krebs solution (composition in mmol/L: 
NaCl 113, KCl 5.9, CaCl2 1.25, MgSO4 1.2, NaH2PO4 
1.2, NaHCO3 25, Glucose 11.5). Chamber temperature 
was kept at 34  °C. A fine nerve branch emanating from 
the pelvic ganglion was dissected and recorded using a 
glass suction electrode filled with the buffer. The colon 
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was catheterized at the both ends in order to apply 
repeated mechanical stimulation by ramp distension 
(0–60 mmHg) at an interval of 15 min. Neuronal signal 
was amplified (Neurolog NL102, Digitimer, UK), filtered 
(band pass 300–3000  Hz) and fed into a computer via 
Micro1401 interface (Cambridge Electronic Design, UK). 
Afferent discharge was saved and processed using spike 
2 software (version 5.14, Cambridge Electronic Design, 
UK). The activity of single units in each recording was 
discriminated by performing the principal component 
analysis of the contour of individual spikes as described 
previously [26]. The same experimental paradigm was 
completed with vehicle-treated control rats (n = 4).
Immunofluorescence (IF) staining
Immunofluorescent staining of the general neuronal 
maker PGP 9.5 and the specific sensory marker CGRP for 
C- and Aδ-fibers [24] were performed in colon from dia-
betic rats (4–5 weeks after induction of diabetes, n = 7) 
and age-matched control rats (n  =  5). Under anesthe-
sia with pentobarbital, rats were transcardially perfused 
with saline followed by 4 % paraformaldehyde and 0.14 % 
picric acid in phosphate buffer (PB, 0.1  mol/L, pH 7.4). 
The colon were removed and post-fixed in the same fixa-
tive overnight at 4 °C and then cryoprotected with 30 % 
sucrose in 0.1 mol/L PB overnight at 4  °C. The samples 
were cut at 16 μm for staining as described previously 
[27]. The sections were first incubated with 0.05  mol/L 
phosphate-buffered saline (PBS) containing 10 % normal 
goat serum and 0.5 % TritonX-100 at room temperature 
for 1  h to block non-specific binding and this was fol-
lowed by incubation with primary rabbit anti-PGP 9.5 
antibody (1:1000, abcam, Cambridge, MA, USA) or rab-
bit anti-CGRP antibody (1:500, abcam, Cambridge, MA, 
USA) at 4  °C overnight. The sections were rinsed with 
PBS for four times and were then incubated with goat 
anti-rabbit Alexa fluor 488 secondary antibody (1:1000; 
Molecular Probes-Invitrogen, Eugene, OR, USA) at room 
temperature for 1  h. After washing with PBS the sec-
tions were mounted on glass slides and viewed under the 
fluorescent microscope (Leica DM2500, Leica Microsys-
tems Limited, USA) and the digital images were analyzed 
using Leica application suite version 4.3 (Leica Microsys-
tems Limited, USA). Nerve fiber density was evaluated 
by counting the number of neurites expressed PGP 9.5 
or CGRP. The number of neurites/mm2 was calculated 
and averaged from six randomized fields for each rat. 
Neurites appeared as thin, relatively straight green lines, 
distinct from the background, sometimes beaded with 
varying width, and sometimes branched. Each straight 
continuous or beaded line was counted as one neurite, 
while the tip of each branch was counted as another neu-
rite, described as previous study [27]. Counts were done 
by two investigators who blinded to the group assign-
ment and calculations were therefore done using aver-
ages of the two sets of counts.
Western blot
Diabetic (n  =  6) and control (n  =  4) rats were deeply 
anesthetized and their colons were removed, frozen 
immediately on dry ice and stored at −80 °C. The samples 
were homogenized in lysis buffer containing 20 mmol/L 
Tris–HCl (pH 8.0), 150 mmol/L NaCl, 1 mmol/L EDTA, 
1 % NP-40, 1 mmol/L PMSF, protease inhibitor cocktail 
(Sigma, St. Louis, MO, USA) and phosphatase inhibitor 
cocktail (Thermo scientific, Indianapolis, IN, USA) for 
1  h at 4  °C. The lysates were centrifuged at 10,000g for 
30 min at 4  °C and the concentration of protein in each 
supernatant was determined using a BCA assay (Pierce, 
Rackford, IL, USA). Thirty-microgram aliquots were sep-
arated on 4–20 % Tris–glycine ready gels (Bio-rad, Her-
cules, CA, USA), the separated proteins were transferred 
from the gel to the surface of Nitrocellulose membranes 
(Bio-rad). The membranes were blocked with 5 % fat-free 
dry milk in Tris-buffered saline (TBS) containing 0.1  % 
Tween-20 for 1  h, and were then incubated for 48  h at 
4  °C with primary rabbit anti-PGP 9.5 antibody (1:200, 
abcam, Cambridge, MA, USA) and with mouse anti-β-
actin antibody (1:2000, abcam) for 2 h at RT, respectively. 
Bound primary antibodies were detected with HRP-con-
jugated anti-rabbit or anti-mouse secondary antibody 
(1:5000, Bio-rad). Immunoreactive bands were visualized 
using enhanced chemiluminescence (Thermo scientific) 
and digital imaging was captured with Image Quant LAS 
4000 mini (GE Healthcare, Life Science, USA). The den-
sity of specific bands was measured with NIH ImageJ 
(http://rsb.info.nih.gov/ij/) software and was normalized 
against a loading control (β-actin). We tried but failed 
to get the CGRP signal (band not at theoretic molecular 
weight, data not shown).
Paw pressure test
One day before VMR measurement, mechanical paw 
withdrawal thresholds (PWTs) were determined by prob-
ing the left hind paw with calibrated Von Frey hairs as 
described previously [28] in diabetic (n = 9) and control 
(n = 7) rats (same rats for VMR study). Von Frey hairs of 
increasing size (hence of increasing force) were applied to 
the plantar surface of the left hind paw until the animal 
withdrew the paw. The smallest size of the von Frey hairs 
required to produce a withdrawal reflex was recorded as 
the threshold.
Statistical analysis
Data were presented as mean  ±  SD. Statistical analysis 
of the data sets was carried out using Graphpad Prism 
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version 3.0 (Graphpad software, La Jolla, CA, USA). Two-
way ANOVA with Bonferroni’s posttest was used to assess 
the difference between experimental groups for blood glu-
cose level and paw withdrawal threshold. To analyze VMR 
and pelvic nerve responses, an X–Y plot analysis was first 
conducted to measure the increases in afferent discharge 
rate from the baseline as the intraluminal pressure rose by 
every 1 mmHg. Such analysis gave rise to individual pres-
sure-afferent response curves and then the group (aver-
age) pressure-afferent response curves. For area under 
the curve (AUC) analysis, the AUC of individual pressure-
afferent response curve was determined and was then 
averaged. Unpaired t-test was used to assess the difference 
in averaged AUC between experimental groups. For PGP 
9.5/CGRP expression analysis, unpaired t-test was used to 
assess difference between experimental groups. Signifi-
cance was set at p < 0.05.
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